Trevor enjoyed a long career with Fairfax Business Media writing on Australian equities for the AFR among other titles.
Paradigm’s share price has increased more than 60% in the last month and it was up more than 12% on Friday.
Establishing a vertically integrated business model provides THC with the ability to optimise efficiencies in the manufacturing process.
The benefits of Admedus' proprietary ADAPT technology and products are now scientifically proven beyond doubt.
The terms of the agreement are based on a minimum initial investment of $18 million for a 60% interest in Admedus Vaccines.
Revenue from the sale of Xprecia Stride™ Coagulation Analyser test strips was $500,000 in the March quarter of 2018.
The pilot project will assess the ResAppDx, ResApp’s smartphone application for diagnosing acute respiratory disease.
Ellex iTrack and Ellex tango™ offer surgeons restorative glaucoma therapy options.
Given recurring revenue streams provide earnings predictability, Volpara is a stock that could generate interest.